• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to project page

2014 Fiscal Year Final Research Report

Functional analysis of MID1 that may be a candidate as a therapeutic target for castration-resistant prostate cancer

Research Project

  • PDF
Project/Area Number 24590463
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Experimental pathology
Research InstitutionNagoya City University

Principal Investigator

TAKAHASHI Satoru  名古屋市立大学, 医学(系)研究科(研究院), 教授 (60254281)

Co-Investigator(Kenkyū-buntansha) SUZUKI Shugo  名古屋市立大学, 大学院医学研究科, 研究員 (60363933)
SATO Shinya  名古屋市立大学, 大学院医学研究科, 研究員 (30464564)
Project Period (FY) 2012-04-01 – 2015-03-31
Keywords前立腺癌 / MID1/TRIM18
Outline of Final Research Achievements

We have established an androgen-independent (AI) subline from androgen-dependent LNCaP cells, and examined genes differentially expressed between LNCaP and LNCaP-AI by microarray analysis. We thereby found midline 1 (MID1) to be an upregulated gene in the latter. Knockdown of MID1 expression in LNCaP-AI cells resulted in significant suppression of invasion, and enforced expression of MID1 in LNCaP promoted an invasive capacity in the Matrigel chemoinvasion assay. MID1 also promoted AR transcriptional activity in gene dosage-dependent manner by luciferase reporter assay. CRYAB, one of upregulated gene in LNCaP-AI cells, promoted invasive ability and knockdown of it led to suppress invasion of prostate cancer cells in the same as MID1. However, interaction between MID1 and CRYAB did not confirmed by immunocytochemistry. These results suggest that MID1 is an AR coactivator and deeply involved in prostate cancer progression via CRYAB with an indirect manner.

Free Research Field

病理学

URL: 

Published: 2016-06-03  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi